SAS and Carolina partner to accelerate antiviral drug development
Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI).
(UNC.edu)
Related: Campus Connections
Chapel Hill-Carrboro Openings, Closings and Updates in October-December 2025The fall marked several Eastgate Crossing shopping center tenants reopening in Chapel Hill after restoration from July’s Tropical Depression Chantal rain and flooding. On October...
Fri Apr 17, 2026Tar Heels fans go bananas for Caleb Wilson before enjoying the Bananas show
Kenan Stadium was packed on a beautiful spring afternoon, and the atmosphere was bananas. And Tar Heels fans went bananas over one of their favorite...
Thu Apr 16, 2026
UNC makes 'new Ivies list for third consecutive year
UNC has made the Forbes list of “new Ivies” for the third straight year. Carolina is the only North Carolina institution on the list, which...
Wed Apr 15, 2026
Savannah Bananas put Bill Belichick to work during Chapel Hill stop
On Saturday, Bill Belichick took a break from spring practice at UNC to try his hand at coaching first base for the Savannah Bananas, who...
Sun Apr 12, 2026
